These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
308 related articles for article (PubMed ID: 29220496)
1. Duration of Influenza Vaccine Effectiveness: A Systematic Review, Meta-analysis, and Meta-regression of Test-Negative Design Case-Control Studies. Young B; Sadarangani S; Jiang L; Wilder-Smith A; Chen MI J Infect Dis; 2018 Feb; 217(5):731-741. PubMed ID: 29220496 [TBL] [Abstract][Full Text] [Related]
2. Vaccine effectiveness in preventing laboratory-confirmed influenza in primary care patients in a season of co-circulation of influenza A(H1N1)pdm09, B and drifted A(H3N2), I-MOVE Multicentre Case-Control Study, Europe 2014/15. Valenciano M; Kissling E; Reuss A; Rizzo C; Gherasim A; Horváth JK; Domegan L; Pitigoi D; Machado A; Paradowska-Stankiewicz IA; Bella A; Larrauri A; Ferenczi A; ; Lazar M; Pechirra P; Korczyńska MR; Pozo F; Moren A; Euro Surveill; 2016; 21(7):pii=30139. PubMed ID: 26924024 [TBL] [Abstract][Full Text] [Related]
3. Beyond Antigenic Match: Possible Agent-Host and Immuno-epidemiological Influences on Influenza Vaccine Effectiveness During the 2015-2016 Season in Canada. Skowronski DM; Chambers C; Sabaiduc S; De Serres G; Winter AL; Dickinson JA; Gubbay JB; Drews SJ; Martineau C; Charest H; Krajden M; Bastien N; Li Y J Infect Dis; 2017 Dec; 216(12):1487-1500. PubMed ID: 29029166 [TBL] [Abstract][Full Text] [Related]
4. Influenza vaccine effectiveness in preventing hospitalizations with laboratory-confirmed influenza in Greece during the 2014-2015 season: A test-negative study. Lytras T; Kossyvakis A; Melidou A; Andreopoulou A; Exindari M; Gioula G; Kalliaropoulos A; Tryfinopoulou K; Pogka V; Spala G; Malisiovas N; Mentis A J Med Virol; 2016 Nov; 88(11):1896-904. PubMed ID: 27088266 [TBL] [Abstract][Full Text] [Related]
5. Integrated Sentinel Surveillance Linking Genetic, Antigenic, and Epidemiologic Monitoring of Influenza Vaccine-Virus Relatedness and Effectiveness During the 2013-2014 Influenza Season. Skowronski DM; Chambers C; Sabaiduc S; De Serres G; Winter AL; Dickinson JA; Gubbay J; Fonseca K; Charest H; Krajden M; Petric M; Mahmud SM; Van Caeseele P; Bastien N; Eshaghi A; Li Y J Infect Dis; 2015 Sep; 212(5):726-39. PubMed ID: 25784728 [TBL] [Abstract][Full Text] [Related]
6. The European I-MOVE Multicentre 2013-2014 Case-Control Study. Homogeneous moderate influenza vaccine effectiveness against A(H1N1)pdm09 and heterogenous results by country against A(H3N2). Valenciano M; Kissling E; Reuss A; Jiménez-Jorge S; Horváth JK; Donnell JM; Pitigoi D; Machado A; Pozo F; Vaccine; 2015 Jun; 33(24):2813-22. PubMed ID: 25936723 [TBL] [Abstract][Full Text] [Related]
7. Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies. Belongia EA; Simpson MD; King JP; Sundaram ME; Kelley NS; Osterholm MT; McLean HQ Lancet Infect Dis; 2016 Aug; 16(8):942-51. PubMed ID: 27061888 [TBL] [Abstract][Full Text] [Related]
8. Higher vaccine effectiveness in seasons with predominant circulation of seasonal influenza A(H1N1) than in A(H3N2) seasons: test-negative case-control studies using surveillance data, Spain, 2003-2011. Savulescu C; Jiménez-Jorge S; Delgado-Sanz C; de Mateo S; Pozo F; Casas I; Larrauri A; Vaccine; 2014 Jul; 32(35):4404-4411. PubMed ID: 24968153 [TBL] [Abstract][Full Text] [Related]
9. Effectiveness of trivalent seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2012/13 end of season results. Andrews N; McMenamin J; Durnall H; Ellis J; Lackenby A; Robertson C; von Wissmann B; Cottrell S; Smyth B; Moore C; Gunson R; Zambon M; Fleming D; Pebody R Euro Surveill; 2014 Jul; 19(27):5-13. PubMed ID: 25033051 [TBL] [Abstract][Full Text] [Related]
10. Influenza vaccine effectiveness among outpatients in the US Influenza Vaccine Effectiveness Network by study site 2011-2016. Balasubramani GK; Nowalk MP; Sax TM; Suyama J; Bobyock E; Rinaldo CR; Martin ET; Monto AS; Jackson ML; Gaglani MJ; Flannery B; Chung JR; Zimmerman RK Influenza Other Respir Viruses; 2020 Jul; 14(4):380-390. PubMed ID: 32298048 [TBL] [Abstract][Full Text] [Related]
11. The Impact of Prior Season Vaccination on Subsequent Influenza Vaccine Effectiveness to Prevent Influenza-related Hospitalizations Over 4 Influenza Seasons in Canada. Nichols MK; Andrew MK; Ye L; Hatchette TF; Ambrose A; Boivin G; Bowie W; Dos Santos G; Elsherif M; Green K; Haguinet F; Katz K; Leblanc J; Loeb M; MacKinnon-Cameron D; McCarthy A; McElhaney JE; McGeer A; Powis J; Richardson D; Semret M; Sharma R; Shinde V; Smyth D; Trottier S; Valiquette L; Webster D; McNeil SA; Clin Infect Dis; 2019 Aug; 69(6):970-979. PubMed ID: 30508064 [TBL] [Abstract][Full Text] [Related]
12. Influenza vaccine effectiveness in preventing inpatient and outpatient cases in a season dominated by vaccine-matched influenza B virus. Martínez-Baz I; Navascués A; Pozo F; Chamorro J; Albeniz E; Casado I; Reina G; Cenoz MG; Ezpeleta C; Castilla J; Hum Vaccin Immunother; 2015; 11(7):1626-33. PubMed ID: 25996366 [TBL] [Abstract][Full Text] [Related]
13. Pooled influenza vaccine effectiveness estimates for Australia, 2012-2014. Sullivan SG; Carville KS; Chilver M; Fielding JE; Grant KA; Kelly H; Levy A; Stocks NP; Tempone SS; Regan AK Epidemiol Infect; 2016 Aug; 144(11):2317-28. PubMed ID: 27125368 [TBL] [Abstract][Full Text] [Related]
14. Influenza vaccine effectiveness in preventing laboratory-confirmed influenza in outpatient settings: A test-negative case-control study in Beijing, China, 2016/17 season. Wu S; Pan Y; Zhang X; Zhang L; Duan W; Ma C; Zhang Y; Zhang M; Sun Y; Yang P; Wang Q; Ma J Vaccine; 2018 Sep; 36(38):5774-5780. PubMed ID: 30087046 [TBL] [Abstract][Full Text] [Related]
15. Influenza A/subtype and B/lineage effectiveness estimates for the 2011-2012 trivalent vaccine: cross-season and cross-lineage protection with unchanged vaccine. Skowronski DM; Janjua NZ; Sabaiduc S; De Serres G; Winter AL; Gubbay JB; Dickinson JA; Fonseca K; Charest H; Bastien N; Li Y; Kwindt TL; Mahmud SM; Van Caeseele P; Krajden M; Petric M J Infect Dis; 2014 Jul; 210(1):126-37. PubMed ID: 24446529 [TBL] [Abstract][Full Text] [Related]
16. Early estimates of influenza vaccine effectiveness in Navarre, Spain: 2012/13 mid-season analysis. Castilla J; Martinez-Baz I; Martinez-Artola V; Fernandez-Alonso M; Reina G; Guevara M; Garcia Cenoz M; Elia F; Alvarez N; Barricarte A; Ezpeleta C Euro Surveill; 2013 Feb; 18(7):2. PubMed ID: 23449182 [TBL] [Abstract][Full Text] [Related]
17. Influenza vaccine effectiveness against laboratory confirmed influenza in Greece during the 2013-2014 season: a test-negative study. Lytras T; Kossyvakis A; Melidou A; Exindari M; Gioula G; Pogka V; Malisiovas N; Mentis A Vaccine; 2015 Jan; 33(2):367-73. PubMed ID: 25448097 [TBL] [Abstract][Full Text] [Related]
18. Understanding influenza vaccine protection in the community: an assessment of the 2013 influenza season in Victoria, Australia. Carville KS; Grant KA; Sullivan SG; Fielding JE; Lane CR; Franklin L; Druce J; Kelly HA Vaccine; 2015 Jan; 33(2):341-5. PubMed ID: 25448093 [TBL] [Abstract][Full Text] [Related]
19. Influenza vaccine effectiveness in the tropics: moderate protection in a case test-negative analysis of a hospital-based surveillance population in Bangkok between August 2009 and January 2013. Levy JW; Simasathien S; Watanaveeradej V; Bhoomiboonchoo P; Fernandez S; Jarman RG; Klungthong C; Gibbons RV; Kerdpanich P; Piboonbanakit D; Chirabandhu T; Yoon IK PLoS One; 2015; 10(8):e0134318. PubMed ID: 26267430 [TBL] [Abstract][Full Text] [Related]
20. Effects of previous episodes of influenza and vaccination in preventing laboratory-confirmed influenza in Navarre, Spain, 2013/14 season. Castilla J; Navascués A; Fernández-Alonso M; Reina G; Albéniz E; Pozo F; Álvarez N; Martínez-Baz I; Guevara M; García-Cenoz M; Irisarri F; Casado I; Ezpeleta C; Euro Surveill; 2016 Jun; 20(22):. PubMed ID: 27277013 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]